{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:06:47Z","timestamp":1785434807627,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-024-05197-3","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T16:08:07Z","timestamp":1733414887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Longitudinal assessment of immunoglobulin response and disease progression in critically ill patients with community acquired pneumonia"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-5723","authenticated-orcid":false,"given":"Emma","family":"Rademaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette M.","family":"Vernooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van der Poll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J. M.","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Leavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf L.","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennie P. G.","family":"Derde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"issue":"8","key":"5197_CR1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00134-015-3845-7","volume":"41","author":"M Shankar-Hari","year":"2015","unstructured":"Shankar-Hari M, Culshaw N, Post B, Tamayo E, Andaluz-Ojeda D, Bermejo-Mart\u00edn JF, et al. Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis. Intensive Care Med. 2015;41(8):1393\u2013401.","journal-title":"Intensive Care Med"},{"issue":"4","key":"5197_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/SHK.0b013e3181a2c0b2","volume":"32","author":"FS Taccone","year":"2009","unstructured":"Taccone FS, Stordeur P, De Backer D, Creteur J, Vincent JL. Gamma-globulin levels in patients with community-acquired septic shock. Shock. 2009;32(4):379\u201385.","journal-title":"Shock"},{"issue":"4","key":"5197_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/joim.12265","volume":"276","author":"JF Bermejo-Mart\u00edn","year":"2014","unstructured":"Bermejo-Mart\u00edn JF, Rodriguez-Fernandez A, Herr\u00e1n-Monge R, Andaluz-Ojeda D, Muriel-Bomb\u00edn A, Merino P, et al. Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. J Intern Med. 2014;276(4):404\u201312.","journal-title":"J Intern Med"},{"issue":"5","key":"5197_CR4","doi-asserted-by":"publisher","first-page":"R247","DOI":"10.1186\/cc13073","volume":"17","author":"EJ Giamarellos-Bourboulis","year":"2013","unstructured":"Giamarellos-Bourboulis EJ, Apostolidou E, Lada M, Perdios I, Gatselis NK, Tsangaris I, et al. Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome. Crit Care. 2013;17(5):R247.","journal-title":"Crit Care"},{"issue":"4","key":"5197_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00134-018-5143-7","volume":"44","author":"T Welte","year":"2018","unstructured":"Welte T, Dellinger RP, Ebelt H, Ferrer M, Opal SM, Singer M, et al. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). Intensive Care Med. 2018;44(4):438\u201348.","journal-title":"Intensive Care Med"},{"issue":"12","key":"5197_CR6","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.intimp.2011.08.024","volume":"11","author":"F Venet","year":"2011","unstructured":"Venet F, Gebeile R, Bancel J, Guignant C, Poitevin-Later F, Malcus C, et al. Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol. 2011;11(12):2086\u201390.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5197_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/infdis\/152.1.4","volume":"152","author":"S Jonsson","year":"1985","unstructured":"Jonsson S, Musher DM, Chapman A, Goree A, Lawrence EC. Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages. J Infect Dis. 1985;152(1):4\u201313.","journal-title":"J Infect Dis"},{"issue":"1","key":"5197_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1186\/s12967-023-04592-8","volume":"21","author":"B Pan","year":"2023","unstructured":"Pan B, Sun P, Pei R, Lin F, Cao H. Efficacy of IVIG therapy for patients with sepsis: a systematic review and meta-analysis. J Transl Med. 2023;21(1):765.","journal-title":"J Transl Med"},{"issue":"1","key":"5197_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13613-019-0501-3","volume":"9","author":"J Cui","year":"2019","unstructured":"Cui J, Wei X, Lv H, Li Y, Li P, Chen Z, Liu G. The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis. Ann Intensive Care. 2019;9(1):27.","journal-title":"Ann Intensive Care"},{"issue":"12","key":"5197_CR10","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1097\/00003246-200712000-00026","volume":"35","author":"K Werdan","year":"2007","unstructured":"Werdan K, Pilz G, Bujdoso O, Fraunberger P, Neeser G, Schmieder RE, et al. Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med. 2007;35(12):2693\u2013701.","journal-title":"Crit Care Med"},{"issue":"5","key":"5197_CR11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/01.CCM.0000215452.84291.C6","volume":"34","author":"M Hentrich","year":"2006","unstructured":"Hentrich M, Fehnle K, Ostermann H, Kienast J, Cornely O, Salat C, et al. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial. Crit Care Med. 2006;34(5):1319\u201325.","journal-title":"Crit Care Med"},{"issue":"4","key":"5197_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/01.shk.0000157302.69125.f8","volume":"23","author":"A Rodr\u00edguez","year":"2005","unstructured":"Rodr\u00edguez A, Rello J, Neira J, Maskin B, Ceraso D, Vasta L, Palizas F. Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock. 2005;23(4):298\u2013304.","journal-title":"Shock"},{"issue":"3","key":"5197_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/376630","volume":"37","author":"J Darenberg","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sj\u00f6lin J, Aufwerber E, Haidl S, Follin P, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37(3):333\u201340.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5197_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/BF00918802","volume":"11","author":"ER Burns","year":"1991","unstructured":"Burns ER, Lee V, Rubinstein A. Treatment of septic thrombocytopenia with immune globulin. J Clin Immunol. 1991;11(6):363\u20138.","journal-title":"J Clin Immunol"},{"key":"5197_CR15","doi-asserted-by":"crossref","unstructured":"Alejandria MM, Lansang MA, Dans LF, Mantaring JB, 3rd. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev. 2013;2013(9):Cd001090.","DOI":"10.1002\/14651858.CD001090.pub2"},{"issue":"11","key":"5197_CR16","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143.","journal-title":"Crit Care Med"},{"issue":"7","key":"5197_CR17","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650\u20137.","journal-title":"Blood"},{"issue":"3","key":"5197_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10875-006-9021-7","volume":"26","author":"HD Ochs","year":"2006","unstructured":"Ochs HD, Gupta S, Kiessling P, Nicolay U, Berger M. Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J Clin Immunol. 2006;26(3):265\u201373.","journal-title":"J Clin Immunol"},{"issue":"4","key":"5197_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jmii.2020.08.013","volume":"54","author":"M Akatsuka","year":"2021","unstructured":"Akatsuka M, Tatsumi H, Sonoda T, Masuda Y. Low immunoglobulin G level is associated with poor outcomes in patients with sepsis and septic shock. J Microbiol Immunol Infect. 2021;54(4):728\u201332.","journal-title":"J Microbiol Immunol Infect"},{"issue":"12","key":"5197_CR20","first-page":"7223","volume":"11","author":"L Tian","year":"2019","unstructured":"Tian L, Zhu J, Jin J, Tong C, Zeng W, Deng S, Zou S. Prognostic value of circulating lymphocyte B and plasma immunoglobulin M on septic shock and sepsis: a systematic review and meta-analysis. Am J Transl Res. 2019;11(12):7223\u201332.","journal-title":"Am J Transl Res"},{"key":"5197_CR21","doi-asserted-by":"crossref","unstructured":"Myrianthefs PM, Boutzouka E, Baltopoulos GJ. Gamma-globulin levels in patients with community-acquired septic shock. Shock. 2010;33(5):556\u20137; author reply 7.","DOI":"10.1097\/01.shk.0000370606.30525.21"},{"issue":"5","key":"5197_CR22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00063-016-0220-6","volume":"112","author":"S Dietz","year":"2017","unstructured":"Dietz S, Lautenschl\u00e4ger C, M\u00fcller-Werdan U, Pilz G, Fraunberger P, P\u00e4sler M, et al. Serum IgG levels and mortality in patients with severe sepsis and septic shock: the SBITS data. Med Klin Intensivmed Notfmed. 2017;112(5):462\u201370.","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"12","key":"5197_CR23","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.rmed.2013.09.005","volume":"107","author":"MC de la Torre","year":"2013","unstructured":"de la Torre MC, Bolibar I, Vendrell M, de Gracia J, Vendrell E, Rodrigo MJ, et al. Serum immunoglobulins in the infected and convalescent phases in community-acquired pneumonia. Respir Med. 2013;107(12):2038\u201345.","journal-title":"Respir Med"},{"issue":"3","key":"5197_CR24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jcv.2013.09.006","volume":"58","author":"M Justel","year":"2013","unstructured":"Justel M, Socias L, Almansa R, Ram\u00edrez P, Gallegos MC, Fernandez V, et al. IgM levels in plasma predict outcome in severe pandemic influenza. J Clin Virol. 2013;58(3):564\u20137.","journal-title":"J Clin Virol"},{"issue":"10","key":"5197_CR25","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1097\/CCM.0b013e3182923712","volume":"41","author":"PM Klein Klouwenberg","year":"2013","unstructured":"Klein Klouwenberg PM, Ong DS, Bos LD, de Beer FM, van Hooijdonk RT, Huson MA, et al. Interobserver agreement of centers for disease control and prevention criteria for classifying infections in critically ill patients. Crit Care Med. 2013;41(10):2373\u20138.","journal-title":"Crit Care Med"},{"issue":"8","key":"5197_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"1","key":"5197_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","volume":"23","author":"S Lambden","year":"2019","unstructured":"Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):374.","journal-title":"Crit Care"},{"issue":"20","key":"5197_CR28","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E","volume":"16","author":"A Cnaan","year":"1997","unstructured":"Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997;16(20):2349\u201380.","journal-title":"Stat Med"},{"issue":"1","key":"5197_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s13054-021-03860-7","volume":"25","author":"K Omiya","year":"2021","unstructured":"Omiya K, Sato H, Sato T, Wykes L, Hong M, Hatzakorzian R, et al. Albumin and fibrinogen kinetics in sepsis: a prospective observational study. Crit Care. 2021;25(1):436.","journal-title":"Crit Care"},{"issue":"11","key":"5197_CR30","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","volume":"166","author":"RS Hotchkiss","year":"2001","unstructured":"Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, Chang KC, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol. 2001;166(11):6952\u201363.","journal-title":"J Immunol"},{"issue":"4","key":"5197_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/SHK.0b013e3181dc0977","volume":"34","author":"F Venet","year":"2010","unstructured":"Venet F, Davin F, Guignant C, Larue A, Cazalis MA, Darbon R, et al. Early assessment of leukocyte alterations at diagnosis of septic shock. Shock. 2010;34(4):358\u201363.","journal-title":"Shock"},{"issue":"7","key":"5197_CR32","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.4049\/jimmunol.1700929","volume":"200","author":"CA Gustave","year":"2018","unstructured":"Gustave CA, Gossez M, Demaret J, Rimmel\u00e9 T, Lepape A, Malcus C, et al. Septic shock shapes B cell response toward an exhausted-like\/immunoregulatory profile in patients. J Immunol. 2018;200(7):2418\u201325.","journal-title":"J Immunol"},{"issue":"1","key":"5197_CR33","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s13054-023-04719-9","volume":"27","author":"M Singer","year":"2023","unstructured":"Singer M, Torres A, Heinz CC, Wei\u00dfm\u00fcller S, Staus A, Kistner S, et al. The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial. Crit Care. 2023;27(1):436.","journal-title":"Crit Care"},{"issue":"6","key":"5197_CR34","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/1753425919853333","volume":"25","author":"C Duerr","year":"2019","unstructured":"Duerr C, Bacher A, de Martin A, Sachet M, Sadeghi K, Baumann S, et al. The novel polyclonal Ab preparation trimodulin attenuates ex vivo endotoxin-induced immune reactions in early hyperinflammation. Innate Immun. 2019;25(6):374\u201388.","journal-title":"Innate Immun"},{"key":"5197_CR35","first-page":"1","volume":"2024","author":"C Jandus","year":"2024","unstructured":"Jandus C, Jandus P. Effects of intravenous immunoglobulins on human innate immune cells: Collegium internationale allergologicum update. Int Arch Allergy Immunol. 2024;2024:1\u201322.","journal-title":"Int Arch Allergy Immunol"},{"issue":"11","key":"5197_CR36","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1097\/CCM.0000000000002627","volume":"45","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari M, Singer M, Spencer J. Can concurrent abnormalities in free light chains and immunoglobulin concentrations identify a target population for immunoglobulin trials in sepsis? Crit Care Med. 2017;45(11):1829\u201336.","journal-title":"Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-024-05197-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T17:02:57Z","timestamp":1733418177000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-024-05197-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5197"],"URL":"https:\/\/doi.org\/10.1186\/s13054-024-05197-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local ethical committee approved the Molecular Diagnosis and Risk Stratification of Sepsis (MARS) cohort and biobank with opt-out consent (Institutional Review Board number 10-056C). Additionally, the use of selected plasma samples from the MARS biobank for this study was approved by the designated committee (TCBio 21\/131).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}